Literature DB >> 22322590

Acid ceramidase-mediated production of sphingosine 1-phosphate promotes prostate cancer invasion through upregulation of cathepsin B.

Thomas H Beckham1, Ping Lu, Joseph C Cheng, Dan Zhao, Lorianne S Turner, Xiaoyi Zhang, Stanley Hoffman, Kent E Armeson, Angen Liu, Tucker Marrison, Yusuf A Hannun, Xiang Liu.   

Abstract

Invasiveness is one of the key features of aggressive prostate cancer; however, our understanding of the precise mechanisms effecting invasion remains limited. The ceramide hydrolyzing enzyme acid ceramidase (AC), overexpressed in most prostate tumors, causes an aggressive and invasive phenotype through downstream effectors that have not yet been well characterized. Here, we demonstrate that AC, through generation of sphingosine-1-phosphate (S1P), promotes Ets1 nuclear expression and binding to the promoter region of matrix-degrading protease cathepsin B. Through confocal microscopy and flow cytometry, we found that AC overexpression promotes pericellular localization of cathepsin B and its translocation to the outer leaflet of the cell membrane. AC overexpressing cells have an increased abundance of cathepsin B-enriched invasive structures and enhanced ability to invade through a collagen matrix, but not in the presence of an inhibitor of cathepsin B. In human prostate tissues, AC and cathepsin B overexpression were strongly associated and may relate to poor outcome. These results demonstrate a novel pathway by which AC, through S1P, promotes an invasive phenotype in prostate cancer by causing overexpression and secretion of cathepsin B through activation and nuclear expression of Ets1. As prostate cancer prognosis is dramatically worse when invasion has occurred, this study provides critical insight into the progression toward lethal prostate cancer.
Copyright © 2012 UICC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22322590      PMCID: PMC3384773          DOI: 10.1002/ijc.27480

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  25 in total

1.  Transcription of human cathepsin B is mediated by Sp1 and Ets family factors in glioma.

Authors:  S Yan; I M Berquin; B R Troen; B F Sloane
Journal:  DNA Cell Biol       Date:  2000-02       Impact factor: 3.311

2.  Extracellular matrix degrading enzymes at the prostasome surface.

Authors:  I Bellezza; M C Aisa; R Palazzo; E Costanzi; E Mearini; A Minelli
Journal:  Prostate Cancer Prostatic Dis       Date:  2005       Impact factor: 5.554

3.  Expression of cathepsins B and S in the progression of prostate carcinoma.

Authors:  P L Fernández; X Farré; A Nadal; E Fernández; N Peiró; B F Sloane; G P Shi; H A Chapman; E Campo; A Cardesa
Journal:  Int J Cancer       Date:  2001-01-20       Impact factor: 7.396

Review 4.  Cathepsin B and tumor proteolysis: contribution of the tumor microenvironment.

Authors:  Bonnie F Sloane; Shiqing Yan; Izabela Podgorski; Bruce E Linebaugh; Michael L Cher; Jianxin Mai; Dora Cavallo-Medved; Mansoureh Sameni; Julie Dosescu; Kamiar Moin
Journal:  Semin Cancer Biol       Date:  2004-12-30       Impact factor: 15.707

5.  Mechanism and regulation of antigen processing by cathepsin B.

Authors:  N Katunuma; Y Matsunaga; T Saibara
Journal:  Adv Enzyme Regul       Date:  1994

6.  Pericellular pH affects distribution and secretion of cathepsin B in malignant cells.

Authors:  J Rozhin; M Sameni; G Ziegler; B F Sloane
Journal:  Cancer Res       Date:  1994-12-15       Impact factor: 12.701

7.  Phenotypic and cytogenetic characterization of a cell line derived from primary prostatic carcinoma.

Authors:  A R Brothman; L J Lesho; K D Somers; G L Wright; D J Merchant
Journal:  Int J Cancer       Date:  1989-11-15       Impact factor: 7.396

8.  Heterogeneous suppression of experimentally induced colon cancer metastasis in rat liver lobes by inhibition of extracellular cathepsin B.

Authors:  C J Van Noorden; T G Jonges; J Van Marle; E R Bissell; P Griffini; M Jans; J Snel; R E Smith
Journal:  Clin Exp Metastasis       Date:  1998-02       Impact factor: 5.150

Review 9.  Molecular regulation of human cathepsin B: implication in pathologies.

Authors:  Shiqing Yan; Bonnie F Sloane
Journal:  Biol Chem       Date:  2003-06       Impact factor: 3.915

10.  Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor.

Authors:  L Foghsgaard; D Wissing; D Mauch; U Lademann; L Bastholm; M Boes; F Elling; M Leist; M Jäättelä
Journal:  J Cell Biol       Date:  2001-05-28       Impact factor: 10.539

View more
  31 in total

Review 1.  Tamoxifen regulation of sphingolipid metabolism--Therapeutic implications.

Authors:  Samy A F Morad; Myles C Cabot
Journal:  Biochim Biophys Acta       Date:  2015-05-09

Review 2.  Cathepsin B as a cancer target.

Authors:  Christopher S Gondi; Jasti S Rao
Journal:  Expert Opin Ther Targets       Date:  2013-01-08       Impact factor: 6.902

Review 3.  Interdiction of sphingolipid metabolism to improve standard cancer therapies.

Authors:  Thomas H Beckham; Joseph C Cheng; S Tucker Marrison; James S Norris; Xiang Liu
Journal:  Adv Cancer Res       Date:  2013       Impact factor: 6.242

Review 4.  Exploring the link between ceramide and ionizing radiation.

Authors:  Massimo Aureli; Valentina Murdica; Nicoletta Loberto; Maura Samarani; Alessandro Prinetti; Rosaria Bassi; Sandro Sonnino
Journal:  Glycoconj J       Date:  2014-10       Impact factor: 2.916

Review 5.  Interdiction of Sphingolipid Metabolism Revisited: Focus on Prostate Cancer.

Authors:  Christina Voelkel-Johnson; James S Norris; Shai White-Gilbertson
Journal:  Adv Cancer Res       Date:  2018-06-20       Impact factor: 6.242

Review 6.  Novel Sphingolipid-Based Cancer Therapeutics in the Personalized Medicine Era.

Authors:  Jeremy Shaw; Pedro Costa-Pinheiro; Logan Patterson; Kelly Drews; Sarah Spiegel; Mark Kester
Journal:  Adv Cancer Res       Date:  2018-06-19       Impact factor: 6.242

Review 7.  Adipose tissue dysfunction and its effects on tumor metabolism.

Authors:  Jonathan Diedrich; Halina Chkourko Gusky; Izabela Podgorski
Journal:  Horm Mol Biol Clin Investig       Date:  2015-01

8.  Loss of acid ceramidase in myeloid cells suppresses intestinal neutrophil recruitment.

Authors:  Mel Pilar Espaillat; Ashley J Snider; Zhijuan Qiu; Breana Channer; Nicolas Coant; Edward H Schuchman; Richard R Kew; Brian S Sheridan; Yusuf A Hannun; Lina M Obeid
Journal:  FASEB J       Date:  2017-12-19       Impact factor: 5.191

9.  Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse.

Authors:  Joseph C Cheng; Aiping Bai; Thomas H Beckham; S Tucker Marrison; Caroline L Yount; Katherine Young; Ping Lu; Anne M Bartlett; Bill X Wu; Barry J Keane; Kent E Armeson; David T Marshall; Thomas E Keane; Michael T Smith; E Ellen Jones; Richard R Drake; Alicja Bielawska; James S Norris; Xiang Liu
Journal:  J Clin Invest       Date:  2013-09-16       Impact factor: 14.808

10.  Akt2 and acid ceramidase cooperate to induce cell invasion and resistance to apoptosis.

Authors:  Norbert Berndt; Ronil Patel; Hua Yang; Maria E Balasis; Saïd M Sebti
Journal:  Cell Cycle       Date:  2013-06-06       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.